486 related articles for article (PubMed ID: 15459175)
1. Reduced penetrance of craniofacial anomalies as a function of deletion size and genetic background in a chromosome engineered partial mouse model for Smith-Magenis syndrome.
Yan J; Keener VW; Bi W; Walz K; Bradley A; Justice MJ; Lupski JR
Hum Mol Genet; 2004 Nov; 13(21):2613-24. PubMed ID: 15459175
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome.
Bi W; Ohyama T; Nakamura H; Yan J; Visvanathan J; Justice MJ; Lupski JR
Hum Mol Genet; 2005 Apr; 14(8):983-95. PubMed ID: 15746153
[TBL] [Abstract][Full Text] [Related]
3. Distorted Mendelian transmission as a function of genetic background in Rai1-haploinsufficient mice.
Girirajan S; Elsea SH
Eur J Med Genet; 2009; 52(4):224-8. PubMed ID: 19116176
[TBL] [Abstract][Full Text] [Related]
4. Rai1 deficiency in mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous mice display minimal behavioral phenotypes.
Bi W; Yan J; Shi X; Yuva-Paylor LA; Antalffy BA; Goldman A; Yoo JW; Noebels JL; Armstrong DL; Paylor R; Lupski JR
Hum Mol Genet; 2007 Aug; 16(15):1802-13. PubMed ID: 17517686
[TBL] [Abstract][Full Text] [Related]
5. Penetrance of craniofacial anomalies in mouse models of Smith-Magenis syndrome is modified by genomic sequence surrounding Rai1: not all null alleles are alike.
Yan J; Bi W; Lupski JR
Am J Hum Genet; 2007 Mar; 80(3):518-25. PubMed ID: 17273973
[TBL] [Abstract][Full Text] [Related]
6. Detection and delineation of an unusual 17p11.2 deletion by array-CGH and refinement of the Smith-Magenis syndrome minimum deletion to approximately 650 kb.
Schoumans J; Staaf J; Jönsson G; Rantala J; Zimmer KS; Borg A; Nordenskjöld M; Anderlid BM
Eur J Med Genet; 2005; 48(3):290-300. PubMed ID: 16179224
[TBL] [Abstract][Full Text] [Related]
7. Behavioral characterization of mouse models for Smith-Magenis syndrome and dup(17)(p11.2p11.2).
Walz K; Spencer C; Kaasik K; Lee CC; Lupski JR; Paylor R
Hum Mol Genet; 2004 Feb; 13(4):367-78. PubMed ID: 14709593
[TBL] [Abstract][Full Text] [Related]
8. A physical map of the mouse shaker-2 region contains many of the genes commonly deleted in Smith-Magenis syndrome (del17p11.2p11.2).
Probst FJ; Chen KS; Zhao Q; Wang A; Friedman TB; Lupski JR; Camper SA
Genomics; 1999 Feb; 55(3):348-52. PubMed ID: 10049592
[TBL] [Abstract][Full Text] [Related]
9. Mosaicism for del(17)(p11.2p11.2) underlying the Smith-Magenis syndrome.
Juyal RC; Kuwano A; Kondo I; Zara F; Baldini A; Patel PI
Am J Med Genet; 1996 Dec; 66(2):193-6. PubMed ID: 8958329
[TBL] [Abstract][Full Text] [Related]
10. Mutations in RAI1 associated with Smith-Magenis syndrome.
Slager RE; Newton TL; Vlangos CN; Finucane B; Elsea SH
Nat Genet; 2003 Apr; 33(4):466-8. PubMed ID: 12652298
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism for duplication 17p11.2- the homologous recombination reciprocal of the Smith-Magenis microdeletion.
Potocki L; Chen KS; Park SS; Osterholm DE; Withers MA; Kimonis V; Summers AM; Meschino WS; Anyane-Yeboa K; Kashork CD; Shaffer LG; Lupski JR
Nat Genet; 2000 Jan; 24(1):84-7. PubMed ID: 10615134
[TBL] [Abstract][Full Text] [Related]
12. Smith-Magenis syndrome.
Elsea SH; Girirajan S
Eur J Hum Genet; 2008 Apr; 16(4):412-21. PubMed ID: 18231123
[TBL] [Abstract][Full Text] [Related]
13. Genomic organisation of the approximately 1.5 Mb Smith-Magenis syndrome critical interval: transcription map, genomic contig, and candidate gene analysis.
Lucas RE; Vlangos CN; Das P; Patel PI; Elsea SH
Eur J Hum Genet; 2001 Dec; 9(12):892-902. PubMed ID: 11840190
[TBL] [Abstract][Full Text] [Related]
14. Gender, genotype, and phenotype differences in Smith-Magenis syndrome: a meta-analysis of 105 cases.
Edelman EA; Girirajan S; Finucane B; Patel PI; Lupski JR; Smith AC; Elsea SH
Clin Genet; 2007 Jun; 71(6):540-50. PubMed ID: 17539903
[TBL] [Abstract][Full Text] [Related]
15. Construction of a natural panel of 11p11.2 deletions and further delineation of the critical region involved in Potocki-Shaffer syndrome.
Wakui K; Gregato G; Ballif BC; Glotzbach CD; Bailey KA; Kuo PL; Sue WC; Sheffield LJ; Irons M; Gomez EG; Hecht JT; Potocki L; Shaffer LG
Eur J Hum Genet; 2005 May; 13(5):528-40. PubMed ID: 15852040
[TBL] [Abstract][Full Text] [Related]
16. Genes in a refined Smith-Magenis syndrome critical deletion interval on chromosome 17p11.2 and the syntenic region of the mouse.
Bi W; Yan J; Stankiewicz P; Park SS; Walz K; Boerkoel CF; Potocki L; Shaffer LG; Devriendt K; Nowaczyk MJ; Inoue K; Lupski JR
Genome Res; 2002 May; 12(5):713-28. PubMed ID: 11997338
[TBL] [Abstract][Full Text] [Related]
17. Array comparative genomic hybridisation of 52 subjects with a Smith-Magenis-like phenotype: identification of dosage sensitive loci also associated with schizophrenia, autism, and developmental delay.
Williams SR; Girirajan S; Tegay D; Nowak N; Hatchwell E; Elsea SH
J Med Genet; 2010 Apr; 47(4):223-9. PubMed ID: 19752160
[TBL] [Abstract][Full Text] [Related]
18. Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) contiguous gene syndromes by chromosome engineering in mice: phenotypic consequences of gene dosage imbalance.
Walz K; Caratini-Rivera S; Bi W; Fonseca P; Mansouri DL; Lynch J; Vogel H; Noebels JL; Bradley A; Lupski JR
Mol Cell Biol; 2003 May; 23(10):3646-55. PubMed ID: 12724422
[TBL] [Abstract][Full Text] [Related]
19. Cloning, genomic structure, and expression of mouse ring finger protein gene Znf179.
Zhao Q; Chen KS; Bejjani BA; Lupski JR
Genomics; 1998 May; 49(3):394-400. PubMed ID: 9615224
[TBL] [Abstract][Full Text] [Related]
20. RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions.
Girirajan S; Elsas LJ; Devriendt K; Elsea SH
J Med Genet; 2005 Nov; 42(11):820-8. PubMed ID: 15788730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
